DBE-T may be a valid therapeutic target for FSHD

FSHD researchers report in Cell that DBE-T may be a valid therapeutic target for FSHD More May 7th joint press release from San Raffaele Scientific Institute, Milan, Italy and the Telethon Foundation can be found Here

Leave a Reply

Your email address will not be published. Required fields are marked *